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EpigeneticsChromatin is themacromolecular nucleoprotein complex that governs the organization of geneticmaterial in the
nucleus of eukaryotic cells. In chromatin, DNA is packed with histone proteins into nucleosomes. Core histones
are prototypes of hyper-modiﬁed proteins, being decorated by a large number of site-speciﬁc reversible and
irreversible post-translational modiﬁcations (PTMs), which contribute to the maintenance and modulation of
chromatin plasticity, gene activation, and a variety of other biological processes and disease states. The observa-
tions of the variety, frequency and co-occurrence of histonemodiﬁcations in distinct patterns at speciﬁc genomic
loci have led to the idea that hPTMs can create amolecular barcode, read by effector proteins that translate it into
a speciﬁc transcriptional state, or process, on the underlying DNA. However, despite the fact that this histone-
code hypothesis was proposed more than 10 years ago, the molecular details of its working mechanisms are
only partially characterized. In particular, two questions deserve speciﬁc investigation: how the different modi-
ﬁcations associate and synergize into patterns and how these PTM conﬁgurations are read and translated by
multi-protein complexes into a speciﬁc functional outcome on the genome. Mass spectrometry (MS) has
emerged as a versatile tool to investigate chromatin biology, useful for both identifying and validating hPTMs,
and to dissect themolecular determinants of histonemodiﬁcation readout systems.We reviewhere theMS tech-
niques and the proteomics methods that have been developed to address these fundamental questions in epige-
netics research, emphasizing approaches based on the proteomic dissection of distinct native chromatin regions,
with a critical evaluation of their present challenges and future potential. This article is part of a Special Issue
entitled: Molecular mechanisms of histone modiﬁcation function.
© 2014 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
In the eukaryotic nucleus, the DNA strand exists in a highly com-
pacted form achieved through winding around histone proteins, there-
by forming a highly structured macromolecular complex, known as
chromatin. The basic unit of chromatin is the nucleosome, which con-
sists of 147 bp of DNAwrapped around an octamer made of two copies
of each canonical histone protein (H3, H2A, H2B and H4) [1,2]. Histones
are highly conserved from yeast to mammals, not only in their primary
sequence, but also in their modiﬁcation status. Histones are prototypes
of hyper-modiﬁed proteins, and are subject to many distinct types of
post-translational modiﬁcations (PTMs) [3], accumulating mainly at
the unstructured N-terminus, which protrudes from the nucleosome
[4].cular mechanisms of histone
y, IEO, Via Adamello 16, 20136
NC-ND license.The co-occurrence of various PTMsdecorating core histones at speciﬁc
genomic loci led to the proposal of a “histone code” [5]. According to this
hypothesis, modiﬁcations on histones act sequentially or in combination
to control the functional state of the underlying DNA [6–9]. In this
sense, chromatin serves as away not only to pack DNA but also to control
when that DNA is used, through the regulation of its compaction and
accessibility to factors that mediate various DNA-based processes.
To decipher the mechanism of action of the hPTM language, it is
essential to understand how a single modiﬁcation, or a combination
thereof, is translated into a speciﬁc functional state. The biological
functions associated with hPTMs are often exerted indirectly (trans-)
through the recruitment or repulsion of speciﬁc proteins or multi-
protein complexes that mediate the signal transduction of these
marks through the execution of various DNA-based processes, such as
gene expression, DNA replication or repair and cell cycle regulation
[10–16]. In a few cases, however, this mechanism is direct (cis-), as it
is for histone hyperacetylation that affects higher-order chromatin fold-
ing and hence its accessibility to nuclear factors both in vitro [17] and
in vivo [18].
Since the ﬁrst proposition of the histone code model, various
methods have been designed to both dissect all existing hPTMs and
Table 1
Strategies for isolation of speciﬁc chromatin regions/loci for subsequent proteomics characterization.
“Swapped-ChIP” approaches Bait Organism References
PICh (Proteomics of Isolated Chromatin) DNA probe complementary to telomeric-repeats H. sapiens
D. melanogaster
[87,88]
Minichromosome afﬁnity puriﬁcation Immobilized-Lac repressor S. cerevisiae [89]
ChAP–MS (chromatin afﬁnity puriﬁcation with mass spectrometry) LexA–PrA or TAL–PrA S. cerevisiae [90,91]
“Conventional ChIP” approaches Bait Organism References
mChIP (modiﬁed chromatin immunopuriﬁcation) Tagged-histone variant or DNA-binding protein or chromatin-binding protein S. cerevisiae [98,99]
ChroP (chromatin proteomics) hPTMs (through antibody) H. sapiens [100]
ChIP-MS (chromatin interacting protein-mass spectrometry) Biotinylated-protein D. melanogaster [101]
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“readers”. Mass spectrometry (MS) andMS-based proteomics, especially
in its quantitative format, have emerged as powerful approaches to gain
a system-level view of the histone code. At the level of individual his-
tones, MS can provide an unbiased and comprehensive map of protein
modiﬁcations, allowing the detection of newmodiﬁcations, revealing in-
terplays among them, and providing an accurate measure of their quan-
titative changes in transitions between distinct functional states [19–23].
Manyproteomics strategies have also beendeveloped to characterize the
composite architecture of chromatin [24–27], demonstrating thatMS is a
fundamental technological platform for research in epigenetics.
A deep comprehension of the histone modiﬁcation functional read-
out requires an understanding of the distinct proteins that interact
with speciﬁc hPTM patterns. These proteins act in concert with other
players, such as other proteins, RNAs and methylated DNA, to enforce
a deﬁned conﬁguration on chromatin.
Comprehensive approaches are needed to capture the complexity of
the numerous physical and functional interactions. Among the various
strategies available, those that combine chromatin immunoprecipita-
tion (ChIP) with mass spectrometry seem particularly well-suited for
this purpose, since they facilitate the parallel analysis of histone marks
and their binding proteins at functionally distinct chromatin regions.
In this review, we will outline themajor achievements of MS for the
investigation of the histone code. We will then describe different func-
tional proteomics strategies available for screening the histone readers.
When ﬁnally focusing on the ChroP approach developed in our group,
we will overview brieﬂy the technical requirements to set-up the
method and outline its strengths and limitations. Lastly, wewill provide
perspectives on developments required to provide the community with
a system-level comprehension of the complex interplays between
hPTM patterns, their readers and writers, chromatin architecture and
the functional readout.2. Overview of MS-proteomics approaches to read the histone code
2.1. Mass spectrometry for the annotation of the hPTM code
2.1.1. MS for PTM identiﬁcation
Histone modiﬁcations have been traditionally studied by means of
speciﬁcally-raised antibodies [28]. Although advantageous for their
sensitivity, antibody-based assays require an a priori knowledge of the
modiﬁcation of interest. In addition, antibodies can suffer from cross-
reactivity with similar modiﬁcations embedded within an identical
amino acid context (e.g. K9 and K27 of histone H3) [29,30]. Moreover,
epitope occlusion effects occur when the detection of a modiﬁcation
is inhibited by the presence of a mark on a neighboring site, as in the
case of H3K9me/S10pho [31]. These events can be frequent in histones,
due to their heavily modiﬁed nature.
In this respect, mass spectrometry (MS) can be very useful. In fact in
MS a post-translational modiﬁcation is detected essentially as a “delta-
mass” (Δm) between the theoretical and experimentally-measuredmasses of a peptide. As such, any possiblemodiﬁcation can be identiﬁed
based on the accurate measurement of the Δm value, with virtually
no limitations concerning the position, number and combinations of
marks present on a polypeptide. Thus, MS distinguishes unambiguously
between near-isobaric modiﬁcations and detects their combinatorial
patterns, even on very long polypeptides and up to intact histones [32,
33,19,34,35,21,36,37]. In addition, the detection of Δm implies that the
technique is an unbiased and efﬁcient means to discover novel marks.
The last ten years have witnessed the publication of an increasing
number of papers describing the successful use ofMS for the annotation
of up to 200 distinct modiﬁcation types [38]. In those that are already
known, new sites have been annotated [39,40], such as for: lysine acet-
ylation, ubiquitylation and SUMOylation; different degrees of lysine and
arginine methylation; serine, tyrosine and threonine phosphorylation;
arginine citrullination; ADP ribosylation and carbonylation. In addition,
MS-based approached have helped to identify novel modiﬁcations such
as lysine propionylation [41] and crotonylation [40]; serine or threonine
O-GlcNAcylation (beta-N-acetylglucosamine) [42–44]. The observation
that some of these new marks have been discovered very recently
suggests that the code is far from being exhaustively uncovered.
2.1.2. MS for quantitation of hPTMs
MS also functions efﬁciently in proﬁling hPTMs across multiple
functional states, using different strategies: chemical labeling, in vivo
metabolic labeling with isotope-encoded amino acids (SILAC) and
SILAC-derived strategies, recently reviewed in [20,23,22,45]. SILAC
was used to proﬁle hPTM dynamics during the cell cycle [46], compare
the marks decorating newly-synthesized versus “old” histones during
protein synthesis [47] and characterize the time-dependent establish-
ment of hPTMs after histone deposition on chromatin [48]. An adapta-
tion of SILAC using a “heavy-labeled spike-in” approach was designed
for the comparative analysis of hPTMs across several breast tumor
samples [49]. Finally, heavy methyl SILAC (hmSILAC, [50]) was success-
fully employed to study histone methylation turnover [51–53]. A
combination of both standard- and heavy methyl-SILAC was used to
proﬁle the dynamics of H3K79 methylation in the cell cycle [54] and
the rates of transition between the different H3K27 and K36 methyla-
tion states [55].
2.1.3. MS to assess hPTM combinatorics
Mass spectrometry is particularly well suited to investigate the
combinatorial association of differentmarkswithin the samemolecules
or even across different histones along nucleosome stretches. In a few
speciﬁc cases, the co-existence or exclusion of distinct marks can be
addressed by shotgunproteomics, upon the use of proteaseswith differ-
ent speciﬁcities than trypsin. The endoproteinase Arg-C for example
cleaves at the amide bond C-terminal to arginine residues and generates
peptides containing multiple modiﬁed residues, such as the peptide aa
(9–17) of histone H3 that allows the simultaneous detection of modiﬁ-
cations on K9 and K14. Similarly, K27 and K36 methylations lie on
the peptide aa (27–40) of H3, as well as the four acetylations on
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distances between cis- and trans- hPTMs remains elusive through
bottom-up approaches because tryptic or Arg-C-derived peptides
are typically too short. For example, although methylated K4 and K36
are both marks of active chromatin, it is not possible to gain hints on
their coexistence on the same H3 molecules because of their distance
along the N-terminus. The synergies between marks in the histone
tails and those laying the globular domains are even less accessible to
investigation by conventional bottom-up MS. In order to address this
aspect, Jaffe and co-workers have described an interesting solution to
assess hPTMcombinations by bottomupMS: they carried out an immu-
noprecipitation of HPLC-puriﬁed soluble H3, using antibodies against
distinctmodiﬁcations (e.g. H3K9me3 andH3K4me3) and then analyzed
PTMs by conventional MS analysis upon Arg-C-like digestion of the
immunopuriﬁed H3. Upon proving the speciﬁcity and selectivity of the
antibody, this method allowed the authors to infer the co-association
of marks within the same molecule, even using a peptide-centric ap-
proach [56]. However, to date, this approach has not been followed by
applications, mainly because of the success of middle- and top-down
MS-based methods. These methods have been used to investigate the
combinatorial aspect of the code through the analysis of large peptide
fragments [57,58], up to intact histone molecules [59–61]. Kelleher
and collaborators have introduced tandem mass spectrometry directly
on intact histones, by means of top-down analysis. Top-downMS relies
on a variety of fragmentation techniques, which largely depend on the
intrinsic properties of the protein ions, such as size, charge and confor-
mation in gas phase. Electron capture (ECD) or Electron transfer (ETD)
dissociations are the most frequently adopted techniques for the frag-
mentation of intact proteins because they are particularly efﬁcient
with high charge state (z N 3) peptides. Through a number of studies,
top-down MS has achieved information about all hPTM combinations
and stoichiometries on the four core histones [62–67]. However, a
major limitation of ECD is the high number of ions generated in a single
fragmentation event, which requires several tandem-spectra to reach a
reasonable signal-to-noise ratio, thus reducing the sensitivity and
compatibility with the liquid chromatography time-scale. Middle-
down approach has emerged as a compromise between bottom-up
and top-down approaches. It enables the analysis of longer peptides
(e.g. the completeN-terminal tail of both H3 andH4) by using proteases
with few digestion sites on histones. Middle-down has been used to
successfully characterize the modiﬁcation patterns and relative stoichi-
ometries of histones H3 and H4 in HeLa cells [57,58,34], and, more
recently, in mouse embryonic stem (ES) cells [68]. Overall, however,
both top-down and middle-down approaches present the challenge of
deconvoluting highly complex tandem mass spectra. Specialized soft-
ware is required to assign multiple co-occurring PTMs to speciﬁc sites
with high conﬁdence and to summarize their complex combinatorial
patterns [69–71]. This issue has limited their dissemination beyond
the circle of groups with expertise in this branch of MS and interests
in epigenetics.
An interesting future perspective might be provided by the re-
cent application of the Orbitrap mass analyzer within the Exactive
instrument to measure protein assemblies up to one megadalton
in size [72]. This implementation opens up the possibility of carrying
out top-down proteomics on the intact histone core octamer, with
the possibility of inferring both inter- and intra-molecular PTM as-
sociations among the different core histones. In fact this platform
was also shown suitable for resolving and quantiﬁes complex glyco-
sylation patterns.
The overall limitation of MS-based analysis of histones is the use
of bulk chromatin preparations as starting sample due to the substantial
amount of material required for theMS-detection of sub-stoichiometric
modiﬁcations. Consequently, the studies described have provided
insights only into global modiﬁcation changes associated with cellular
functional transitions, like developmental switches, cell-cycle stages,
depletion of gene products, and chemical inhibitions of speciﬁchistone-modifying enzymes, but they have fallen short in assessing
distinct hPTM patterns at functionally distinct genomic loci. In this
sense, analytical solutions to carry out hPTM analyses of physically
more restricted chromatin regions are highly desirable.
2.2. Screening of hPTM readers
2.2.1. Identiﬁcation of readers by afﬁnity pull-down SILAC screening
MS-based interactomics has been successfully employed in a num-
ber of biochemical assays aimed at screening for histone code readers.
These types of experiments permit an unbiased, proteome-wide screen-
ing of binders of distinct modiﬁcations on histones, providing a useful
alternative to educated approaches in which readers are extrapolated
on the basis of protein domains known to mediate speciﬁc hPTM–
protein interactions [73–76].
The general experimental design, common to all different proteomic-
afﬁnity interaction strategies, can be synthesized as follows: an in-
teraction proﬁling is carried out based on a pull-down experiment
where nucleosolic extracts are incubated with selected components of
chromatin — bearing single modiﬁcations or combinations thereof. This
is followed by LC-MS/MS-based identiﬁcation of the proteins retained
on the solid support (typically beads), which are classiﬁed as potential
binders when they are measured as enriched relative to the unmodiﬁed
version of the samebait (themock control). Since one feature of protein–
protein interactions mediated by PTMs is the relatively low afﬁnity,
the identiﬁcation of hPTM readers by conventional proteomics may
be challenged by the difﬁculty in enriching and discriminating
speciﬁc interactors from co-puriﬁed “hitch-hiker” proteins. In this
sense, coupling afﬁnity-based enrichment with quantitative proteo-
mics methods, such as SILAC, has signiﬁcantly enhanced the efﬁciency
of these screenings.
Allis and co-workers ﬁrst conceived the scheme of this assay, how-
ever using conventional single gel-band MS-analysis to identify WDR5
and BPTF, which appeared as enriched protein bands in a Coomassie
SDS-PAGE, upon a pull-down using a histone H3 peptide bearing tri-
methylation on lysine 4 (H3K4me3) [77,78]. Through a collaborative
effort, Vermeulen et al. used the same afﬁnity pull-down assay using
peptides mimicking modiﬁed H3-tails, but combined it with SILAC to
annotate the complete repertoire of H3K4me3-interacting proteins by
shotgun proteomics [79] (Fig. 1A, left). This study not only conﬁrmed
previous results but also identiﬁed novel readers of H3K4me3. For
instance, the entire TFIID complex is recruited at this modiﬁcation
through the binding of TAF3 via its plant homeodomain (PHD) ﬁnger.
This approach was then extended by carrying out a comparative study
on a panel of peptides bearing tri-methylation at distinct lysines of
H3 (K4, K9, K27 and K36) and of H4 (K20), leading to the acquisition
of the histone lysine tri-methyl-interactome [80]. The combina-
tion of SILAC-interactomics with ChIP-Seq proﬁling and BAC-GFP
transgeneOmics helped to reconstruct the complex architecture of
these interactions and to gain mechanistic insights into the regulation
of gene expression mediated by these modiﬁcations.
Along the same lines, Kapoor and co-workers developed the CLASPI
approach, where the SILAC pull-down is implemented through the use
of photo-cross-linking peptide probes that mimic methylated histone
tails. This approach has the advantage of converting weak protein-
PTM interactions into covalent ones, which allows one to capture also
additional binders that had escaped non-covalent screenings [81].
Following these initial studies, two main implementations of the
pull-down assay have been characterized by the use of more sophisti-
cated baits, with the rationale that some interactions between histone
marks and their respective readers may be inﬂuenced by the native
environment. Low afﬁnity readers could indeed bind more speciﬁcally
and efﬁciently to hPTMs embeddedwithin thewhole histonemolecule,
up to the intact nucleosomes, compared tomodiﬁcations present on lin-
ear peptides. In fact, it has already been observed that certain histone
modifying enzymes (HME) do not recognize peptides as substrates
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Fig. 1. Strategies for enriching hPTM- and chromatin-binding proteins. A) Pull-down based approaches to characterize readers of hPTMs using different baits: immobilized histone
modiﬁcation peptides (left), recombinant nucleosomes bearing a combination of hPTMs and methylated DNA (middle) or recombinant modiﬁed chromatin (right). B) “Swapped-
ChIP” strategies allow isolating speciﬁc DNA domain or native locus, using either a complementary DNA probe (upper) or TAL effector protein matching to a speciﬁc chromosome section
(i.e. the promoter region of GAL1) (lower), respectively. Conventional chromatin immunoprecipitation strategies enable to isolate chromatin sections using antibodies against histone
variants (left), hPTMs (middle), or biotinylated proteins (right) as bait. Green and orange hexagons correspond to methylated and acetylated histone protein, respectively. Red hexagon
corresponds, instead, to methylated DNA.
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mono-nucleosome templates, reconstituted in vitro starting from DNA
stretches and recombinant histones, uniformly modiﬁed at speciﬁc
residues, have been employed to assess the combined contribution of
both DNA and histone methylations in recruiting speciﬁc readers onto
chromatin (Fig. 1A, middle). This approach, named SNAP (SILAC nucle-
osome afﬁnity puriﬁcation), revealed that UHRF1 and ORC bind the
H3K9me3-modiﬁednucleosomeswhen the CpGmethylation is present.
In contrast, the H3K36 demethylase KDM2A is enriched in H3K9me3-
nucleosomes but its recruitment is inhibited by DNA methylation, thus
highlighting the real combinatorial effect of DNAand PTMmodiﬁcations
in recruiting proteins [83]. Similarly, nucleosome arrays, where a
recombinant chromatin template uniformly tri-methylated on H3K4
and H3K9, or mono-ubiquitylated on H2BK120, were used in SILAC-
based afﬁnity puriﬁcation experiments (Fig. 1A, right) [84,85]. The
observation of a limited overlap between the interactomes obtained
using as baits either chromatin or histone peptides bearing the same
modiﬁcation corroborates the initial intuition that the context in which
an hPTM is embedded can have a signiﬁcant impact on the recruitment
of certain readers and suggests that in vitro approaches to investigate
the histone readout may have intrinsic biases.
With respect to educated approaches, afﬁnity-interactomics strate-
gies are comprehensive, having the advantage of unraveling not only
direct but also secondary interactions, as for the recruitment of multi-
protein complexes, illustrated in the case of TFIID bound to H3K4me3
peptides [79]. Furthermore, the use of recombinant, in vitro re-
constituted systems offers the opportunity of manipulating precisely
the type, composition and combination of modiﬁcations, which, in
turn, enables the validation of experimentally well-deﬁned synergisms
or antagonisms among epigenetic marks. For instance, the synergy of
H3K4me3 with H3K9/K14 acetylation in recruiting TFIID and BPTF has
been demonstrated, while H3S10 phosphorylationwas shown to desta-
bilize CDYL but not HP1 binding to H3K9me3 [80]. On the other hand,
major limitations reside in the fairly artiﬁcial conditions of thescreening. For example, the modiﬁcations of these recombinant tem-
plates are stoichiometric and thus these methods do not reproduce
their physiological abundances, which instead are in several cases
sub-stoichiometric compared to the unmodiﬁed counterpart, as ob-
served in a number of MS-studies where the relative abundance of
PTMs was estimated through intensity-based quantitation of unmodi-
ﬁed and modiﬁed peaks [49,86,65]. This can impact the actual binding
afﬁnity of the readers. Hence, although useful and informative in the
discovery phase, up to now these in vitro approaches have not been
exploited to their maximum potential, by taking into account both the
real modiﬁcation abundance and arrangements and all other chromatin
determinants existing at speciﬁc regions, to generate a picture that
would reﬂect more faithfully the native code-to-reader interplays.
2.2.2. Methods based on the isolation of native chromatin
With respect to in vitro afﬁnity screening, approaches based on the
proteomics dissection of afﬁnity-enriched native chromatin have the ad-
vantage of enabling the parallel investigation of both hPTMs and readers
natively co-occurring at deﬁned regions (See Table 1). The ﬁrst example
of a strategy based on biochemical isolation of a physically and function-
ally discrete chromatin region for the subsequent characterization of its
protein composition by MS is the PICh (Proteomics of Isolated
Chromatin) approach — an elegant method where the puriﬁcation of
cross-linked human and Drosophila melanogaster telomeres is achieved
using DNA probes complementary to these regions [87,88]. One limita-
tion of PICh is that its application is restricted to regions rich in repetitive
DNA sequences. However, the PICh approach is a milestone because it
demonstrated for the ﬁrst time that chromatin afﬁnity-puriﬁcation can
be successfully combined with MS-proteomics, and thus paved the way
for the design of other strategies based on the same “swapped-ChIP”
rationale. In contrast to conventional ChIP, where proteins or PTMs are
used as baits to isolate DNA before qPCR proﬁling or sequencing, the
logic of “swapped-ChIP” is to use DNA as the baits, or “handles”, for
sequence-speciﬁc isolation of distinct chromatin regions, speciﬁc to a
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dissected by high-resolution mass spectrometry.
A number of assays have been established in Saccharomyces
cerevisiae, a model system that can be genetically engineered to gener-
ate solutions for isolation of chromatin pieces. Tsukiyama and co-
workers generated from the yeast genome a TRP1–ARS1–LacO mini-
chromosome that contains the TRP1 gene, an efﬁcient early-ﬁring origin
of replication gene and the lac operator sequence (LacO) [89]. Using an
immobilized lac repressor, they afﬁnity-puriﬁed the mini-chromosome
from whole cell extracts for subsequent MS-analysis of both the hPTMs
andproteins associatedwith the origin of replication at speciﬁc stages of
the cell cycle. This approach uncovered that the dynamic regulation of
histones H3 and H4 amino-terminal acetylation around ARS1 facilitates
ﬁring of endogenous origins at chromosomal locations, thus correlating
a set of hPTMs with DNA replication.
With a similar strategy, the group of Tackett presented ChAP–MS
as the approach that truly combines ChIP and MS to investigate both
proteins and histone post-translational modiﬁcations associated to a
single genomic locus [90]. The GAL1 locus from budding yeast in tran-
scriptionally silent and active conditions was puriﬁed through the use
of a single genomic LeX-A DNA binding site. The DNA afﬁnity handle
was inserted just upstream of the GAL1 start codon via homologous
recombination in a strain constitutively expressing a LexA–ProteinA
(LexA–PrA) fusion protein. Thus, the strain contains an ectopically
expressed afﬁnity-tagged LexA protein with an incorporated DNA afﬁn-
ity handle for site-speciﬁc chromatin isolation. The yeast strain was cul-
tured in either glucose or galactose to achieve repression or activation of
the GAL1 gene, respectively. In addition, the authors combined the
LexA–PrA puriﬁcation with quantitative proteomics based on iDIRT
(isotopic differentiation of interactions as random or targeted) labeling
to discern speciﬁc interactors from background proteins. However, the
authors did not carry out the MS-based analysis of PTMs of histones
from the enriched chromatin, hence the comprehensive view of locus-
speciﬁc hPTM patterns remained unaddressed and it represents an
attractive aspect to investigate in the future. A limit of ChAP–MS is
that it operationally relies on genetic engineering of the budding yeast
genome, possible in this model system but less straightforward in
higher eukaryotes. However, themethod is conceptually very attractive
and suitable for interesting applications. One of them is the TAL–ChAP–
MS approach, an implementation that allows enrichment of native
genomic loci without genetic engineering [91]. Taking advantage of
the transcription activator-like (TAL) ProteinA as an afﬁnity handle, a
small section of chromatin upstream of the GAL1 locus was isolated
and subsequently MS-analyzed to identify histone marks and proteins
mediating transcriptional activation of the gene. Label-free quantitative
proteomicswasused insteadof an isotope-labeling approach for protein
quantitation. The possibility to ‘re-program’ theDNA-binding speciﬁcity
of the TAL protein to obtain a unique afﬁnity puriﬁcation reagent for
each chromosome region of interest holds great promises in enabling
the widespread investigation of chromatin composition and epigenetic
states of various yeast genetic loci. However, its application for in-
depth analyses of hPTMs and to other model organisms has not yet
been described.
Alternatives to the “swapped-ChIP” strategy include methods that
use conventional chromatin immunoprecipitation (ChIP) (Fig. 1B) to
isolate distinct genomic regions for subsequent proteomic analysis. In
its usual set-up, and through the analysis of the isolated DNA using
PCR, DNA microarray (ChIP-on-chip) or deep sequencing (ChIP-Seq),
ChIP allows the acquisition of genome-wide proﬁles of various
chromatin-components with a resolution of a few nucleosomes
[92–97]. The strengths of ChIP-Seq are: the dissemination of themethod
among many laboratories; its robustness, achieved through several
years of optimization of reagents (antibodies), protocols (cross-linking,
immuno-afﬁnity step), data analysis and the creation of data reposito-
ries for the sharing and comparison of results. The major drawback is
that individual marks are analyzed in each experiment, which limitsthe assessment of multiple PTM types and the co-occupancy of inter-
actors on single nucleosomes.
In the proteomics equivalent of ChIP, the immunoprecipitation is
followed by MS-analysis to identify qualitatively and quantitatively
the hPTMs, histone variants and chromatin-binding proteins that are
isolated together with the modiﬁcation or protein used as “bait”. ChIP-
MS methods have the advantage of being directly derived from
standardized protocols of cross-linked chromatin immunoprecipitation,
which should facilitate their adoption among scientists. However, the
adaptation of conventional ChIP to proteomics has remained at a con-
cept stage for long and only recently been achieved, upon a few techno-
logical achievements. First, it has become possible to analyze proteins
obtained from formaldehyde cross-linked samples. Second, the higher
sensitivity and increased dynamic range of recent mass spectrometers
have facilitated detection of low abundance, sub-stoichiometric post-
translational modiﬁcations from small quantities of starting histones.
In this respect, it is worthmentioning that, despite these improvements
in instrumentation and the considerable scale-down of ChIP experi-
ments, the starting material required for in-depth proteomics analyses
of afﬁnity-isolated chromatin is still 1–2 orders of magnitude more
than what is required for traditional ChIP-Seq.
The ﬁrst method that merged ChIP with MS was described by Figey
and co-workers in 2007, and named mChIP (modiﬁed chromatin
immunopuriﬁcation). This approach consists in the isolation of chroma-
tin by afﬁnity-enrichment of DNA-bound proteins; it was applied to the
analysis of the interactome of nucleosomes containing the S. cerevisiae
histone variants Hta2p and Htz1p [98]. The same authors followed up
the technique with the ﬁrst large-scale mChIP characterization of the
chromatin interactome in budding yeast using 100 DNA- or chromatin-
binders as baits. MS was used to identify the novel chromatin proteins
associated with these baits, generating of a vast network of novel associ-
ations grounded on chromatin [99]. The limitations of the mChIP ap-
proach are twofold: ﬁrst, it lacks quantitative methods to discern
speciﬁc interactors from the classical chromatin background. Second,
the histone code readout was not dissected, because the study was not
focused on the analysis of hPTM patterns on the enriched chromatin.
Recently, our group has implemented the ChroP approach where a
standard ChIP, using as baits two marks associated with functionally
distinct chromatin regions (H3K9me3 and H3K4me3), was combined
with MS-SILAC based quantitative proteomics. This approach allowed
the comprehensive investigation of the histone modiﬁcation and vari-
ants as well as the co-interacting chromatin proteins that co-associate
at speciﬁc regions to enforce deﬁnite functional states (the so-called
“chromatome”) [100]. Being based on the enrichment of intact mono-
nucleosomes at quasi-purity, ChroP enables observations of inter-
molecular synergisms between modiﬁcations decorating different core
histones within the same nucleosome. In addition, it allows for the
ﬁrst time assessments of the region-speciﬁc compartmentalization of
histone variants and linker histone subtypes. Since the investigation of
such proteins has been held back by the lack of good quality antibodies,
ChroP is uniquely efﬁcient in investigating their genomic distribution
and speciﬁc role. The ChroP protocol is essentially the same used in
ChIP-Seq, thus the two assays are highly complementary. We envisage
that a single scale-up ChIP experiment can be carried out and a minor
fraction of the sample is used for deep sequencing, while the remaining
is subjected to MS analysis. ChroP and ChIP-Seq are two sides of the
same coin: the former dissects the physical associations among distinct
determinants of chromatin and the latter indicates the genome-wide
localization of such composite architectures.
However, the current version of ChroP suffers from some restraints,
outlined in Section 4, which will be overcome through future technical
and functional implementations of the method (see 4.1 and 4.2). For
instance, the current examples of ChroP's application in the literature
imply the use of trypsin and Arg-C to digest enriched histones prior to
MS. In this way, long-distance synergies have to be inferred from the
data, rather than being documented by direct observed co-occurrence
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K29/K36). Thus, distinguishing cis- and trans-occurrences and inter/
intra-co-occurrence of PTMs on histone molecules is not possible, in
the present setup. In perspective, the combination of ChroP with the
use of top-down and middle-down MS strategies will enable one to
assess long-distance PTM synergisms (see 4.2). In addition, the use of
ChIP-grade antibodies against hPTMs in ChroP is at the same time ad-
vantageous, as it makes the method an exact complement to ChIP-Seq,
and limiting, since most antibodies are polyclonal thus heterogeneous
in their efﬁciency/speciﬁcity, which could affect ChroP robustness.
Consequently we have experienced that ChroP needs case-by-case
optimization, depending on the antibody speciﬁcity and modiﬁcation
abundance in the cell type under investigation (see paragraph 3.2 for
more details).
In this light, there is promise in those strategies that take advantage
of in vivo tagging of endogenous proteins/modiﬁcations to generate a
standardized afﬁnity-puriﬁcation method. The ChIP-MS (chromatin
interacting protein-mass spectrometry) method, described by Kuroda
and co-workers, uses as bait an in vivo biotinylated version of
D. melanogasterMSL3 andMSL2 proteins, upon the insertion of a bacte-
rial HBT tag into their genes [101]. Since MSL2 and 3 are subunits of
the fruit ﬂy Dosage Compensation Complex (DCC), the MS analysis of
the isolated cross-linked chromatin leads to the proteomic dissection
of MSL-bound chromatin. Through this strategy two novel candidate
subunits of the complexwere identiﬁed (CG1832 and CG4747 proteins)
and validated by functional assays. The authors used a TAP-tagged
version of MSL3 to carry out the analysis of MSL-associated hPTMs.
They found that H4K16 acetylation is a hallmark of DCC-bound chroma-
tin and thatmethylatedH3K36 andH3K79 are also strongly enriched, in
line with previous literature [102,103,92,104,105]. This work on DCC
reveals potential novel determinants of the transcriptional state of
the male X chromosome genes and offers insights onto novel hPTM-
reader associations, such as the one between H3K36me3 and CG4747.
However, possible limitations include the lack of a comprehensive
quantitative analysis of hPTMs across the distinct core histones of the
DCC-bound nucleosome, and the use of genetically engineered MSL2
and MSL3 genes for tag-based afﬁnity chromatin puriﬁcation. Even if
this is straightforward in fruit ﬂy, the strategy may be more laborious
in mammals.
3. ChroP for region-speciﬁc dissection of chromatin
proteomic composition
3.1. Essentials of N-ChroP and X-ChroP protocols and representative results
ChroP articulates into two distinct protocols, depending on the ques-
tion addressed by MS and the corresponding type of chromatin used as
input. In N-ChroP, unﬁxed, native chromatin digested with MNase is
employed to purify mono-nucleosomes from bulk chromatin and to
evaluate the co-enriched hPTM patterns. Instead, X-ChroP consists in
the afﬁnity-isolation of cross-linked sonicated chromatin fragments car-
ried out in conjunction with a peptide competition assay and SILAC-
based quantitative proteomics to discern genuine binders from unspe-
ciﬁc background proteins [106–108,79]. Technical details of X-ChroP
and N-ChroP protocols are provided [100,109]; hence, in this section
we will offer a more conceptual overview of the crucial steps in the
procedures, illustrating their similarities and differences and describing
the visualization of typical results.
N- and X-ChroP are comparable in their basic experimental design
(Fig. 2A), aside from the use of native versus formaldehyde cross-
linked chromatin and of unlabeled versus SILAC-labeled samples,
respectively. Brieﬂy, a ChIP-grade antibody against a speciﬁc histone
modiﬁcation is incubated with the fragmented chromatin. Proteins as-
sociated to isolated chromatin regions are recovered and processed
prior to mass spectrometry. This step consists in protein separation by
SDS-PAGE; in-gel digestion of proteins using site-speciﬁc proteases;extraction and de-salting of peptides that are ﬁnally separated by
reversed-phase liquid chromatography and analyzed by tandem mass
spectrometry (RP-LC–MS/MS). While the processing of MS raw data
from N- and X-ChroP for both hPTM and protein identiﬁcation
is based on the use of a speciﬁc search engine (Mascot [110] and
Andromeda [111], respectively), the relative quantiﬁcation of his-
tone modiﬁcations and of putative interactors is carried out in differ-
ent ways. In particular, in N-ChroP, all identiﬁed hPTMs are validated
bymanual inspection of the correspondingMS/MS spectra. Label free
quantiﬁcation is achieved ﬁrst by calculating the relative abundance
(RA) of each modiﬁcation using the signal intensity of the unmodi-
ﬁed and modiﬁed species for the corresponding peptide and, secondly,
by estimating the relative enrichment (RE) of each modiﬁcation in the
immunoprecipitated octamer relative to input. Once the enrichment
of the modiﬁcation used as bait is veriﬁed, the co-association or deple-
tion of all other modiﬁcations is assessed, both at the intra-molecular
level and at the inter-molecular level on co-puriﬁed core histones with-
in the isolated nucleosome. This creates the so-called “region-speciﬁc
modiﬁcome”, where positive and negative cross-talks between hPTMs
are annotated and visualized through a heatmap display (Fig. 2B). In
X-ChroP assays instead, speciﬁc co-isolated proteins are identiﬁed
through a combination of SILAC and competition assays using an excess
of the soluble histone peptide, bearing the modiﬁcation, which is used
as bait. The soluble peptide added in excess in one of the two SILAC-
ChIP channels saturates the binding capacity of the antibody and thus
“competes out” the large proportion of nucleosomes containing the
bait and, accordingly, all speciﬁc interactors that are discerned from
background based on their speciﬁc SILAC H/L ratio (Fig. 2C).
3.2. Fine tuning of the procedure, with critical steps and tricks
The ChroP protocol was conceived directly from the standard chro-
matin immunoprecipitation protocol [112], with minor adaptations to
MS. Yet, a number of critical aspects have been addressed during the
set-up of the method; this section illustrates them, alongside with the
solutions implemented and critical assessment on their beneﬁts.
In ChroP, the length of the native nucleosome array obtained by
either enzymatic (MNase) or mechanical (sonication) fragmentation
of chromatin is very important and must be established depending
on the different aims of the analysis. We chose to use as input for
N-ChroP a fraction almost completely enriched in mono-nucleosomes,
because we were particularly interested in dissecting the physical asso-
ciation of hPTMs across different core-histoneswithin the distinct intact
mono-nucleosomes. To ascertain that isolated nucleosomes are intact,
the appropriate stoichiometry of the four different core-histones in the
immunopuriﬁed material was carefully evaluated in the Coomassie-
stained gel. A lack of the proper stoichiometry is indicative of partial
disruption of the nucleosome, with impossibility of investigating inter-
molecular cross-talks.
Comparing the PTM patterns obtained using nucleosome stretches
of different lengths to be used as input for N-ChroP is an interesting
development of the technique that enables assessment of the frequency
of distinct PTMcombinations along chromatin. For such analysis, homo-
geneous nucleosome stretches of precise length must be used, which
can be puriﬁed through CsCl ultracentrifugation [113] or sucrose gradi-
ent centrifugation [114,115] of MNase-digested chromatin. Reinberg
and co-workers have recently developed this idea, using a chromatin
preparation containing 94% mono-nucleosomes, puriﬁed through
sucrose gradient centrifugation, as input for the immunoprecipitation
step, to assess if the two copies of histones are symmetrically or
asymmetrically modiﬁed in vivo [116]. They could demonstrate that
nucleosomes in ES, MEF and HeLa cells can exist in both symmetrically
and asymmetrically modiﬁed forms for H3K27 di-/tri-methylation
and H4K20 mono-methylation. Moreover, they propose that the ac-
tivity of the Polycomb repressive complex-2 (PRC2) is inhibited only
when the nucleosomes contain symmetrically active marks, such as
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Fig. 2.ChroP approach for identifying and quantifyinghPTMsor binding proteins co-associatedwith functionally distinct chromatin regions. A) Schematic overviewof theChroPworkﬂow.
Chromatin from labeled or unlabeled cells is fragmented using sonication (upper panel) or MNase (bottom panel). Puriﬁcation of speciﬁc functional chromatin domains is obtained by
incubating the chromatin with antibodies against either a speciﬁc hPTM or a non-histonic nuclear protein; in the X-ChroP approach one of the two chromatin samples is incubated
with the same antibody saturated with an excess of soluble peptide. Immunopuriﬁed proteins are separated by SDS-PAGE and in-gel digested and analyzed by LC-MS/MS. Finally,
MS raw data are analyzed, deﬁning the SILAC ratio of the co-immunopuriﬁed proteins (upper panel) or comparing the relative abundance of hPTMs in immunoprecipitated material
relative to input (bottom panel). B) The enrichment/depletion of co-associating hPTMs identiﬁed on histones H3, H4 and H2 is shown through a heatmap representation, where each
row corresponds to a differentmodiﬁcations (n.d.: not detectedmodiﬁcations), while column corresponds to distinct chromatin regions. C) Proteins co-enriched within the same regions
can be discerned from background based on their SILAC-ratio: background proteins (gray) cluster around protein ratio 1, while speciﬁc binders are in the top-right quadrant of the scatter
plot (yellow).
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allow a more accurate quantiﬁcation of the relative stoichiometry of
modiﬁcations, both at the intra- and inter-molecular level, elucidating
the real co-association or depletion between the different hPTMs. In
X-ChroP we chose 300–500 bp chromatin stretches as input for ChIP,
reasoning that multi-protein complexes recruited at modiﬁed chroma-
tin typically include distinct proteins containing binding modules,
which interact either with modiﬁcations present at distinct sites along
the same histone molecule, or on different core histones, or even on
molecules in neighboring nucleosomes. In any case, when nucleosomes
of different lengths are under investigation, an increase or decrease in
enzymatic or mechanical fragmentation is used to obtain chromatin
enriched in mono- or poly-nucleosomes, respectively. While MNase
digestion of native chromatin can be tuned more ﬁnely to achieve
more homogeneous and reproducible nucleosome stretches, the precise
control of formaldehyde-ﬁxed chromatin sonication is challenging.
Testing different cross-linking conditions or agents will in the future
permit enzymatic digestions of ﬁxed-chromatin, thus combining the
advantages of cross-linking stabilization of low afﬁnity and transient
interactions (required when the bait is a DNA- or histone-binding pro-
tein) with the higher reproducibility of enzymatic digestion.
Another crucial step is the deﬁnition of the optimal ratio between
the amounts of input chromatin and of antibody, which changes case
by case, depending on the relative abundance of the hPTM/protein
used as bait and on the antibody efﬁciency. Optimization is typically
achieved experimentally, by comparing the abundance of the bait ininput and its residual in the ﬂow-through (FT) upon ChIP. If the bait is
sufﬁciently depleted in FT (at least 50–60% depletion) one can trust
that a signiﬁcant proportion of the region of interest is enriched, thus
excluding a bias due to the analysis of a not representative sub-fraction.
Finally, the optimal molar excess of the soluble peptide with respect
to the antibody must be carefully titrated case by case. Also in this
case the optimization is reached experimentally, by performing a com-
petition ChIP assay with increasing concentrations of the excess
peptide followed by an evaluation of the amount of bait in the
immunoprecipitated samples and in the FT. We found that the ideal
excess of soluble peptide typically reduces about 20 times the
amount of bait retained on the beads. This number is, on the one hand,
sufﬁciently large to beneﬁt from the SILAC discriminating power, and
on the other hand, not too extreme to induce the complete eviction of
speciﬁc binders from the antibody,whichwould causemissingH/L ratios
for quantiﬁcation and statistical analysis.
4. Present limitations and future implementations of ChIP-based
proteomics analyses of the histone PTM readout
Approaches based on chromatin-IP followed by the MS-investigation
of region-speciﬁc chromatin determinants have so far been described
in proof-of-principle studies, where the validation of already known
markers/determinants of well-characterized chromatin regions has
corroborated the robustness of the strategies.We envisage that a number
of implementations will be beneﬁcial to gain a more comprehensive
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methods can affect both technical aspects and functional applications.
We will offer some examples of possible developments, being aware
that other ideas can stem from the creativity of individuals or the urge
to answer speciﬁc biological questions.4.1. Technical/biochemical implementations
A needed extension in order tomake the ChroP a closer complement
of ChIP-Seq for all protein determinants of chromatin, involves the use
of either DNA-binding proteins or secondary chromatin interactors
which recognize either hPTMs or DNA-bound factors, as baits. This
implementation should be straightforward for all the factors for which
a conventional ChIP has already been established, upon case-by-case
optimization and tailoring the protocols for chromatin cross-linking to
further stabilize secondary interactions and thus increase immunopre-
cipitation efﬁciency.
Applying ChroP/ChIP-MS strategies to in vivo tagging systems of en-
dogenous proteins is highly appealing, due to the possibility of using a
universal tag for immuno-afﬁnity capture, which would facilitate the
standardization of the protocol into a “universal chromatin proteomics”
approach. An example of a tagging strategy is the BAC-recombineering
method, where endogenous proteins were expressed as GFP fusions
in HeLa S3 and used for pull-down in conjunction with quantitative
proteomics for a standardized multiplexed analysis of the mitotic
interactome [117,118]. Similarly, a biotin tag can be inserted upon
in vivo protein biotinylation, introducing an exogenous biotin ligase
gene (BirA/biotinylation tag system) [119–121]. Recently the BICON
(Biotinylation-assisted Isolation of CO-modiﬁed Nucleosomes) method
has been described, which uses exactly this strategy: the histone-
modifying enzyme MSK1 was biotinylated and streptavidin was used
to purify co-modiﬁed nucleosomes [122]. In this study the analysis
for co-associating modiﬁcations was assessed only by western blot
approach, thereby lacking the precision gained by MS. Alternatively,
in vivo biotinylation can also be achieved using the endogenous biotin
ligase enzyme to biotinylate the target gene, as in ChIP-MS strategy
[101].
The use of universal tags paves the way to another crucial imple-
mentation: namely the elution of immuno-enriched chromatin from
the beads by competing with excess of the soluble tag. This is the ﬁrst
step towards the transition from in-gel to gel-free methods for pre-MS
sample preparation, which will eventually permit the acquisition of
whole region-speciﬁc chromatomes in one single LC-MS/MS run.
Thanks to the new Orbitrap-based mass spectrometers, such as the
Q-Exactive, which have high MS/MS identiﬁcation rates, combined
with ultra high-pressure liquid chromatography (UHPLC) for peptide
separation prior to ESI [123–125], it is now possible to comprehensively
analyze sub-proteomes without the need of pre-MS protein separation
and with relatively short LC gradients. The possibility of eluting isolated
pieces of chromatin in solutionwithout the interference of the immuno-
globulin chains will make it possible to multiplex chromatomics analy-
sis upon preparative ChIP.
Recently, a genome-engineering tool based on the RNA-guided
Cas9 nuclease [126] from the clustered regularly interspaced short
palindromic repeats (CRISPR) system was used successfully to in-
duce precise cleavages at deﬁned endogenous genomic loci also in
human and mouse cells [127,128]. The CRISPR/Cas system facilitates
genetic engineering in comparison to other genome-editing tech-
nologies, like zinc ﬁngers (ZNs) and transcription activator like
effectors (TALEs), enabling a spectrum of different modiﬁcations of
the genome [129]. Furthermore, multiple guide sequences can be
encoded into a single CRISPR array, thus leading the simultaneous
editing of several sites within the mammalian genome, expanding
the range of applicability of RNA-guided nuclease technology. In this
respect, the CRISPR/Cas system may represent in the future anotheruseful tool to isolate speciﬁc genomic regions for subsequent proteo-
mics investigation.
4.2. Functional implementations
Time-dependent studies are a very attractive functional applica-
tion of ChroP. ChIP is carried out serially, at different time-points of
a biological process that encompasses dynamic changes in chromatin
composition and state. For instance, it would be extremely interesting
to investigate the dynamics of hPTMs, variants and interactors clustering
at speciﬁc chromatin regions during the differentiation of embryonic
stem cells, or upon a perturbation that induces global transcriptional ac-
tivation, such as an inﬂammatory stimulus that elicits transcriptional ac-
tivation of a large set of genes in immuno-competent cells [130–133]. In
such studies, triple SILAC can be elegantly used in different experimental
set-ups to proﬁle chromatin composition at multiple time-points, as
was elegantly demonstrated for the analysis of the phosphoproteome
dynamics upon EGF stimulus [134]. Alternatively, recent achievements
in label-free quantiﬁcation (LFQ) can be beneﬁcial for the quantitative
proﬁling of proteins and modiﬁcations across multiple samples [135,
65,33]. While static ChIP-MS analysis provides ﬁxed snap-shots on
locus-speciﬁc chromatin composition, time-dependent studies will
boost the understanding of chromatin plasticity during transitions
between different gene expression states, offering novel insights into
the timing and sequential translation of the code into the corresponding
functional readouts.
In this perspective, we count on the fact that in the future it will be
possible to combine ChroP with targeted quantitative proteomics ap-
proaches [136–144] as an alternative to shotgun analysis. The rationale
is that after a discovery phase, where conventional ChroP/ChIP-MS
serves to annotate the molecular signature of discrete genomic regions,
targeted proteomics will help to monitor a well-deﬁned set of novel in-
teresting determinants in a multiplexed experimental design, without
the need for SILAC labeling. Using prototypic peptides for each determi-
nant, it will be possible to estimate their locus-speciﬁc enrichment
or depletion in time-depended analysis upon various perturbations
(e.g. differentiation stimuli, depletion of histone modifying enzymes,
structural components). Another advantage in using targeted proteo-
mics is the possibility to deﬁne the correct stoichiometry between the
protein subunits of a speciﬁc complex associatedwith different chroma-
tin regions. Analogous to the relationship between ChIP-Seq and ChIP-
PCR, where the former provides a global picture of the distribution of
a certain factor and the latter a view on enrichment at a speciﬁc gene,
ChroP-targeted proteomics will extend the functionality of ChroP by
enabling a very focused view of the changes in the composite architec-
ture of chromatin.
Finally, an interesting development originates from the limitation of
bottomupMS in assessing long-distance cross-talks among histonemod-
iﬁcations, as a consequence of the fact that trypsin and Arg-C produce
short peptides containing a limited number of co-occurringmarks. An ob-
vious follow-up is to analyze the nucleosomes isolated by preparative
ChIP through a combination of bottom-up, middle- and top-down MS,
to achieve a bird-eye view of the long-distance connectivity among his-
tone marks at speciﬁc chromatin regions [145]. Although appealing, this
application is not straightforward and requires a number of technical
modiﬁcations to theprotocol. First, so far,middle- and top-downmethods
have been employed only on bulk histone preparation due to the signiﬁ-
cantly larger amount of starting material required. It remains to be veri-
ﬁed whether a reasonable scale-up of ChroP can meet with an
equivalent increase in top-down sensitivity to make this experiment fea-
sible [61]. In addition, sincemiddle- and top-downapproaches analyze ei-
ther intact molecules or long (25–50aa) peptides produced by using
proteases that are typically not active in gel (e.g. Asp-N and Glu-C),
there is a need to set-up alternative elutions that solubilize chromatin
and make them compatible with gel-free protein separation, such as the
GELFrEE (gel-eluted liquid fraction entrapment electrophoresis) system
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and top-down is highly challenging and yet worth the effort, since it
appears as the sole strategy capable of revealing all hPTMcross-talks asso-
ciatedwith functionally-distinct chromatin regions and thus relating such
patterns of histone post-translational modiﬁcation with functional states.
4.3. Implemented methods for bioinformatics analysis of the chromatome
Althoughmass spectrometry technology has accelerated research in
chromatin biology during the past decade, signiﬁcant computational
challenges still remain before we can obtain a system view of hPTM
readout. Speciﬁcally, new methods are required for the quantitative
exploration and visualization of hPTM combinations.
A number of bioinformatics tools have been developed that can
interpret spectra from modiﬁed peptide sequences produced by
bottom-up approaches, including sequences derived from histones.
However, obtaining information on the combinatorics of hPTMs would
be helped by MS-based proteomics approaches that produce informa-
tion on much longer peptides or intact proteins, such as middle-down
and top-down approaches describedpreviously in this review. Although
data analysis has beneﬁted from the introduction of instruments with
high mass measurement accuracy, algorithms available to deconvolute
the highly complex mass spectra produced by these approaches are
still lacking [148]. These spectra are complicated by the larger analyte
size, the greater numbers of fragment ions and the presence of different
structural isomers of the same modiﬁed proteins. Currently, there are
two popular tools available for the analysis of middle- and top-down
data: ProSightPTM [149], the ﬁrst software developed for analysis of
intact proteins, searches the Uniprot database which contains known
modiﬁcations and variations in protein sequences. An extended version
of Mascot called BIG Mascot [150] has also been developed, which in-
creases the precursor ion mass limit from 16 kDa to 110 kDa. In these
middle-down and top-down approaches it is clear that, although these
methods can provide quantitative information on the stoichiometries
of whole or larger sets of hPTMcombinations, gaining accurate informa-
tion on the nature and localization of hPTMs is currently only available
through bottom-up approaches. While middle- and top-downmethods
and instrumentation continues to develop, is therefore clear that algo-
rithms are needed that combine robustly identiﬁed and localized
hPTMswith the stoichiometric information gained from comprehensive
approaches.
5. Conclusive remarks: novel frontiers for a systems view of the
hPTM readout
One cannot disregard that the information obtained from genomics
and proteomics data on chromatin are highly complementary. A further
challenge therefore lies in the development of additional bioinformatics
methods that integrate these data andoffer new formats of visualization
that, ideally, retain information on the chromatin organization. This
information has been lacking in the one-dimensional chromosome
walks of current genome browsers, commonly associated with geno-
mics methods such as ChIP-Seq [151]. With respect to visualization,
some developments have already taken place in this direction, such as
the Hilbert space-ﬁlling curve representation used by Kharchenko
et al. [152]. In their work, the authors elegantly map a set of nine pre-
dicted chromatin states, based on a set of selected hPTM combinations,
to folded views of ﬂy chromosomes, thereby revealing domains that are
biologically signiﬁcant but would not be easily discerned from a linear
view, such as those corresponding to transcriptional elongation in
heterochromatic regions. One could envisage the beneﬁts of deﬁning
speciﬁc combinations of hPTMs, obtained by MS-based proteomics
approaches, in a nucleosome- and locus-speciﬁc manner, and then
mapping this information to a spatially-organized region of the genome.
As these approaches would also include information on the writers
and readers of hPTMs, and conceivably permit the dimension of time-dependent analyses, the integration of genomics and proteomics
information would enable one to capture important insights into the
complex physical–functional interplays that occur between the com-
binations of hPTMs present, the factors that bind these regions, the
architecture of the recruiting chromatin and the functional readout of
histone modiﬁcations.
Acknowledgements
Wewish to thankA. Cuomoand R. Noberini for critical reading of the
manuscript and discussion. TB work is supported by grants from the
Giovanni Armenise-Harvard Foundation Career Development Program,
the Italian Association for Cancer Research (AIRC) (cod. 11786 and cod.
10000), EPIGEN ﬂagship project Grant (Conv. attuativa-Sottoprog. 6.7)
and the ItalianMinistry of Health (GR-2009-1580495).Wewish to ded-
icate this article to the memory of the Count Giovanni (Nino) Auletta
Armenise, founder of the Giovanni Armenise-Harvard Foundation for
Scientiﬁc Research.
References
[1] R.D. Kornberg, Chromatin structure: a repeating unit of histones and DNA, Science
184 (1974) 868–871.
[2] K. Luger, A.W. Mader, R.K. Richmond, D.F. Sargent, T.J. Richmond, Crystal structure
of the nucleosome core particle at 2.8 A resolution, Nature 389 (1997) 251–260.
[3] T. Kouzarides, Chromatin modiﬁcations and their function, Cell 128 (2007)
693–705.
[4] P. Tropberger, R. Schneider, Going global: novel histonemodiﬁcations in the globular
domain of H3, Epigenetics 5 (2010) 112–117.
[5] B.D. Strahl, C.D. Allis, The language of covalent histone modiﬁcations, Nature 403
(2000) 41–45.
[6] A.J. Bannister, T. Kouzarides, Regulation of chromatin by histonemodiﬁcations, Cell
Res. 21 (2011) 381–395.
[7] O.J. Rando, Combinatorial complexity in chromatin structure and function:
revisiting the histone code, Curr. Opin. Genet. Dev. 22 (2012) 148–155.
[8] E.I. Campos, D. Reinberg, Histones: annotating chromatin, Annu. Rev. Genet. 43
(2009) 559–599.
[9] R. Margueron, D. Reinberg, Chromatin structure and the inheritance of epigenetic
information, Nat. Rev. Genet. 11 (2010) 285–296.
[10] D.J. Patel, Z. Wang, Readout of epigenetic modiﬁcations, Annu. Rev. Biochem. 82
(2013) 81–118.
[11] T. Jenuwein, C.D. Allis, Translating the histone code, Science 293 (2001) 1074–1080.
[12] S.D. Taverna, H. Li, A.J. Ruthenburg, C.D. Allis, D.J. Patel, How chromatin-binding
modules interpret histone modiﬁcations: lessons from professional pocket pickers,
Nat. Struct. Mol. Biol. 14 (2007) 1025–1040.
[13] M. Yun, J. Wu, J.L. Workman, B. Li, Readers of histone modiﬁcations, Cell Res. 21
(2011) 564–578.
[14] K.L. Yap, M.M. Zhou, Keeping it in the family: diverse histone recognition by con-
served structural folds, Crit. Rev. Biochem. Mol. Biol. 45 (2010) 488–505.
[15] S. Khorasanizadeh, Recognition of methylated histones: new twists and variations,
Curr. Opin. Struct. Biol. 21 (2011) 744–749.
[16] C. Martin, Y. Zhang, The diverse functions of histone lysine methylation, Nat. Rev.
Mol. Cell Biol. 6 (2005) 838–849.
[17] M. Shogren-Knaak, H. Ishii, J.M. Sun, M.J. Pazin, J.R. Davie, C.L. Peterson, Histone
H4-K16 acetylation controls chromatin structure and protein interactions, Science
311 (2006) 844–847.
[18] A. Akhtar, P.B. Becker, Activation of transcription through histone H4 acetylation by
MOF, an acetyltransferase essential for dosage compensation in Drosophila, Mol.
Cell 5 (2000) 367–375.
[19] S. Sidoli, L. Cheng, O.N. Jensen, Proteomics in chromatin biology and epigenetics:
elucidation of post-translational modiﬁcations of histone proteins by mass spec-
trometry, J. Proteome 75 (2012) 3419–3433.
[20] L.M. Britton, M. Gonzales-Cope, B.M. Zee, B.A. Garcia, Breaking the histone code
with quantitative mass spectrometry, Expert Rev. Proteome 8 (2011) 631–643.
[21] M.D. Plazas-Mayorca, B.M. Zee, N.L. Young, I.M. Fingerman, G. LeRoy, S.D. Briggs,
B.A. Garcia, One-pot shotgun quantitative mass spectrometry characterization of
histones, J. Proteome Res. 8 (2009) 5367–5374.
[22] B.M. Zee, N.L. Young, B.A. Garcia, Quantitative proteomic approaches to studying
histone modiﬁcations, Curr. Chem. Genomics 5 (2011) 106–114.
[23] B.A. Garcia, Mass spectrometric analysis of histone variants and post-translational
modiﬁcations, Front. Biosci. (Schol. Ed.) 1 (2009) 142–153.
[24] H.C. Eberl, M. Mann, M. Vermeulen, Quantitative proteomics for epigenetics,
Chembiochem 12 (2011) 224–234.
[25] T. Bartke, J. Borgel, P.A. DiMaggio, Proteomics in epigenetics: new perspectives for
cancer research, Brief. Funct. Genomics 12 (2013) 205–218.
[26] M. Soldi, A. Cuomo, M. Bremang, T. Bonaldi, Mass spectrometry-based proteomics
for the analysis of chromatin structure and dynamics, Int. J. Mol. Sci. 14 (2013)
5402–5431.
[27] Y. Han, B.A. Garcia, Combining genomic and proteomic approaches for epigenetics
research, Epigenomics 5 (2013) 439–452.
666 M. Soldi et al. / Biochimica et Biophysica Acta 1839 (2014) 657–668[28] L. Perez-Burgos, A.H. Peters, S. Opravil,M. Kauer, K.Mechtler, T. Jenuwein,Generation
and characterization of methyl-lysine histone antibodies, Methods Enzymol. 376
(2004) 234–254.
[29] Y. Liu, S.D. Taverna, T.L. Muratore, J. Shabanowitz, D.F. Hunt, C.D. Allis, RNAi-
dependent H3K27 methylation is required for heterochromatin formation and
DNA elimination in Tetrahymena, Genes Dev. 21 (2007) 1530–1545.
[30] I. Bock, A. Dhayalan, S. Kudithipudi, O. Brandt, P. Rathert, A. Jeltsch, Detailed spec-
iﬁcity analysis of antibodies binding to modiﬁed histone tails with peptide arrays,
Epigenetics 6 (2011) 256–263.
[31] P. Cheung, Generation and characterization of antibodies directed against di-
modiﬁed histones, and comments on antibody and epitope recognition, Methods
Enzymol. 376 (2004) 221–234.
[32] M.B. Trelle, O.N. Jensen, Functional proteomics in histone research and epigenetics,
Expert Rev. Proteomics 4 (2007) 491–503.
[33] B.A. Garcia, J. Shabanowitz, D.F. Hunt, Characterization of histones and their post-
translational modiﬁcations by mass spectrometry, Curr. Opin. Chem. Biol. 11
(2007) 66–73.
[34] S.D. Taverna, B.M. Ueberheide, Y. Liu, A.J. Tackett, R.L. Diaz, J. Shabanowitz, B.T.
Chait, D.F. Hunt, C.D. Allis, Long-distance combinatorial linkage between methyla-
tion and acetylation on histone H3 N termini, Proc. Natl. Acad. Sci. U. S. A. 104
(2007) 2086–2091.
[35] H.C. Beck, Mass spectrometry in epigenetic research, Methods Mol. Biol. 593
(2010) 263–282.
[36] A. Villar-Garea, A. Imhof, The analysis of histone modiﬁcations, Biochim. Biophys.
Acta 1764 (2006) 1932–1939.
[37] J.D. Tipton, J.C. Tran, A.D. Catherman, D.R. Ahlf, K.R. Durbin, N.L. Kelleher, Analysis of
intact protein isoformsbymass spectrometry, J. Biol. Chem. 286 (2011) 25451–25458.
[38] A.M. Arnaudo, B.A. Garcia, Proteomic characterization of novel histone post-
translational modiﬁcations, Epigenetics Chromatin 6 (2013) 24.
[39] F. Casadio, X. Lu, S.B. Pollock, G. LeRoy, B.A. Garcia, T.W. Muir, R.G. Roeder, C.D. Allis,
H3R42me2a is a histone modiﬁcation with positive transcriptional effects, Proc.
Natl. Acad. Sci. U. S. A. 110 (2013) 14894–14899.
[40] M. Tan, H. Luo, S. Lee, F. Jin, J.S. Yang, E. Montellier, T. Buchou, Z. Cheng, S.
Rousseaux, N. Rajagopal, Z. Lu, Z. Ye, Q. Zhu, J. Wysocka, Y. Ye, S. Khochbin, B.
Ren, Y. Zhao, Identiﬁcation of 67 histone marks and histone lysine crotonylation
as a new type of histone modiﬁcation, Cell 146 (2011) 1016–1028.
[41] Y. Chen, R. Sprung, Y. Tang, H. Ball, B. Sangras, S.C. Kim, J.R. Falck, J. Peng, W. Gu, Y.
Zhao, Lysine propionylation and butyrylation are novel post-translational modiﬁ-
cations in histones, Mol. Cell. Proteomics 6 (2007) 812–819.
[42] R. Fujiki,W. Hashiba, H. Sekine, A. Yokoyama, T. Chikanishi, S. Ito, Y. Imai, J. Kim, H.H.
He, K. Igarashi, J. Kanno, F. Ohtake, H. Kitagawa, R.G. Roeder, M. Brown, S. Kato,
GlcNAcylation of histone H2B facilitates its monoubiquitination, Nature 480 (2011)
557–560.
[43] K. Sakabe, Z. Wang, G.W. Hart, Beta-N-acetylglucosamine (O-GlcNAc) is part of the
histone code, Proc. Natl. Acad. Sci. U. S. A. 107 (2010) 19915–19920.
[44] S. Zhang, K. Roche, H.P. Nasheuer, N.F. Lowndes, Modiﬁcation of histones by sugar
beta-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone
H3 serine 10, and is cell cycle-regulated, J. Biol. Chem. 286 (2011) 37483–37495.
[45] M.Nikolov, C. Schmidt, H. Urlaub, Quantitativemass spectrometry-based proteomics:
an overview, Methods Mol. Biol. 893 (2012) 85–100.
[46] J.J. Pesavento, H. Yang, N.L. Kelleher, C.A. Mizzen, Certain and progressive methyl-
ation of histone H4 at lysine 20 during the cell cycle, Mol. Cell. Biol. 28 (2008)
468–486.
[47] D. Bonenfant, H. Towbin,M. Coulot, P. Schindler, D.R. Mueller, J. van Oostrum, Anal-
ysis of dynamic changes in post-translational modiﬁcations of human histones
during cell cycle bymass spectrometry, Mol. Cell. Proteomics 6 (2007) 1917–1932.
[48] A.N. Scharf, K. Meier, V. Seitz, E. Kremmer, A. Brehm, A. Imhof, Monomethylation of
lysine 20 on histone H4 facilitates chromatin maturation, Mol. Cell. Biol. 29 (2009)
57–67.
[49] A. Cuomo, S. Moretti, S. Minucci, T. Bonaldi, SILAC-based proteomic analysis to
dissect the “histone modiﬁcation signature” of human breast cancer cells, Amino
Acids 41 (2011) 387–399.
[50] S.E. Ong, G. Mittler, M. Mann, Identifying and quantifying in vivo methylation sites
by heavy methyl SILAC, Nat. Methods 1 (2004) 119–126.
[51] B.M. Zee, R.S. Levin, B. Xu, G. LeRoy, N.S. Wingreen, B.A. Garcia, In vivo residue-
speciﬁc histone methylation dynamics, J. Biol. Chem. 285 (2010) 3341–3350.
[52] X.J. Cao, B.M. Zee, B.A. Garcia, Heavy methyl-SILAC labeling coupled with liquid
chromatography and high-resolution mass spectrometry to study the dynamics
of site-speciﬁc histone methylation, Methods Mol. Biol. 977 (2013) 299–313.
[53] B.D. Fodor, S. Kubicek, M. Yonezawa, R.J. O'Sullivan, R. Sengupta, L. Perez-
Burgos, S. Opravil, K. Mechtler, G. Schotta, T. Jenuwein, Jmjd2b antagonizes
H3K9 trimethylation at pericentric heterochromatin in mammalian cells, Genes
Dev. 20 (2006) 1557–1562.
[54] S.M. Sweet, M. Li, P.M. Thomas, K.R. Durbin, N.L. Kelleher, Kinetics of re-
establishing H3K79 methylation marks in global human chromatin, J. Biol. Chem.
285 (2010) 32778–32786.
[55] Y. Zheng, S.M. Sweet, R. Popovic, E. Martinez-Garcia, J.D. Tipton, P.M. Thomas, J.D.
Licht, N.L. Kelleher, Total kinetic analysis reveals how combinatorial methylation
patterns are established on lysines 27 and 36 of histone H3, Proc. Natl. Acad. Sci.
U. S. A. 109 (2012) 13549–13554.
[56] S.E. Peach, E.L. Rudomin, N.D. Udeshi, S.A. Carr, J.D. Jaffe, Quantitative assessment of
chromatin immunoprecipitation grade antibodies directed against histone modiﬁ-
cations reveals patterns of co-occurring marks on histone protein molecules, Mol.
Cell. Proteomics 11 (2012) 128–137.
[57] B.A. Garcia, J.J. Pesavento, C.A. Mizzen, N.L. Kelleher, Pervasive combinatorial mod-
iﬁcation of histone H3 in human cells, Nat. Methods 4 (2007) 487–489.[58] N.L. Young, P.A. DiMaggio, M.D. Plazas-Mayorca, R.C. Baliban, C.A. Floudas, B.A.
Garcia, High throughput characterization of combinatorial histone codes, Mol.
Cell. Proteomics 8 (2009) 2266–2284.
[59] J.J. Pesavento, Y.B. Kim, G.K. Taylor, N.L. Kelleher, Shotgun annotation of histone
modiﬁcations: a new approach for streamlined characterization of proteins by
top down mass spectrometry, J. Am. Chem. Soc. 126 (2004) 3386–3387.
[60] L.M. Smith, N.L. Kelleher, Proteoform: a single term describing protein complexity,
Nat. Methods 10 (2013) 186–187.
[61] K.R. Durbin, J.C. Tran, L. Zamdborg, S.M. Sweet, A.D. Catherman, J.E. Lee, M. Li, J.
F. Kellie, N.L. Kelleher, Intact mass detection, interpretation, and visualization
to automate top-down proteomics on a large scale, Proteomics 10 (2010)
3589–3597.
[62] C.E. Thomas, N.L. Kelleher, C.A. Mizzen, Mass spectrometric characterization of
human histone H3: a bird's eye view, J. Proteome Res. 5 (2006) 240–247.
[63] M.T. Boyne II, J.J. Pesavento, C.A. Mizzen, N.L. Kelleher, Precise characterization of
humanhistones in theH2A gene family by top downmass spectrometry, J. Proteome
Res. 5 (2006) 248–253.
[64] N. Siuti, M.J. Roth, C.A. Mizzen, N.L. Kelleher, J.J. Pesavento, Gene-speciﬁc character-
ization of human histone H2B by electron capture dissociation, J. Proteome Res. 5
(2006) 233–239.
[65] J.J. Pesavento, C.A. Mizzen, N.L. Kelleher, Quantitative analysis of modiﬁed proteins
and their positional isomers by tandem mass spectrometry: human histone H4,
Anal. Chem. 78 (2006) 4271–4280.
[66] Y. Zheng, P.M. Thomas, N.L. Kelleher, Measurement of acetylation turnover at
distinct lysines in human histones identiﬁes long-lived acetylation sites, Nat.
Commun. 4 (2013) 2203.
[67] J.J. Pesavento, C.R. Bullock, R.D. LeDuc, C.A. Mizzen, N.L. Kelleher, Combinatorial
modiﬁcation of human histone H4 quantitated by two-dimensional liquid chroma-
tography coupled with top down mass spectrometry, J. Biol. Chem. 283 (2008)
14927–14937.
[68] H.R. Jung, S. Sidoli, S. Haldbo, R.R. Sprenger, V. Schwammle, D. Pasini, K. Helin, O.N.
Jensen, Precision mapping of coexisting modiﬁcations in histone H3 tails from
embryonic stem cells by ETD-MS/MS, Anal. Chem. 85 (2013) 8232–8239.
[69] P.A. DiMaggio Jr., N.L. Young, R.C. Baliban, B.A. Garcia, C.A. Floudas, A mixed integer
linear optimization framework for the identiﬁcation and quantiﬁcation of targeted
post-translational modiﬁcations of highly modiﬁed proteins using multiplexed
electron transfer dissociation tandem mass spectrometry, Mol. Cell. Proteomics 8
(2009) 2527–2543.
[70] A.M. Frank, J.J. Pesavento, C.A. Mizzen, N.L. Kelleher, P.A. Pevzner, Interpreting top-
down mass spectra using spectral alignment, Anal. Chem. 80 (2008) 2499–2505.
[71] S. Guan, A.L. Burlingame, Data processing algorithms for analysis of high resolution
MSMS spectra of peptides with complex patterns of posttranslational modiﬁca-
tions, Mol. Cell. Proteomics 9 (2010) 804–810.
[72] R.J. Rose, E. Damoc, E. Denisov, A.Makarov, A.J. Heck, High-sensitivity Orbitrapmass
analysis of intact macromolecular assemblies, Nat. Methods 9 (2012) 1084–1086.
[73] X. Shi, I. Kachirskaia, K.L. Walter, J.H. Kuo, A. Lake, F. Davrazou, S.M. Chan, D.G. Martin,
I.M. Fingerman, S.D. Briggs, L. Howe, P.J. Utz, T.G. Kutateladze, A.A. Lugovskoy, M.T.
Bedford, O. Gozani, Proteome-wide analysis in Saccharomyces cerevisiae identiﬁes
several PHD ﬁngers as novel direct and selective binding modules of histone H3
methylated at either lysine 4 or lysine 36, J. Biol. Chem. 282 (2007) 2450–2455.
[74] P. Filippakopoulos, S. Picaud, M. Mangos, T. Keates, J.P. Lambert, D. Barsyte-Lovejoy,
I. Felletar, R. Volkmer, S. Muller, T. Pawson, A.C. Gingras, C.H. Arrowsmith, S. Knapp,
Histone recognition and large-scale structural analysis of the humanbromodomain
family, Cell 149 (2012) 214–231.
[75] Y. Yang, Y. Lu, A. Espejo, J. Wu, W. Xu, S. Liang, M.T. Bedford, TDRD3 is an effector
molecule for arginine-methylated histone marks, Mol. Cell 40 (2010) 1016–1023.
[76] S. Maurer-Stroh, N.J. Dickens, L. Hughes-Davies, T. Kouzarides, F. Eisenhaber, C.P.
Ponting, The Tudor domain ‘Royal Family’: Tudor, plant Agenet, Chromo, PWWP
and MBT domains, Trends Biochem. Sci. 28 (2003) 69–74.
[77] J.Wysocka, T. Swigut, T.A.Milne, Y. Dou, X. Zhang, A.L. Burlingame, R.G. Roeder, A.H.
Brivanlou, C.D. Allis, WDR5 associates with histone H3 methylated at K4 and is
essential for H3 K4 methylation and vertebrate development, Cell 121 (2005)
859–872.
[78] J. Wysocka, T. Swigut, H. Xiao, T.A. Milne, S.Y. Kwon, J. Landry, M. Kauer, A.J.
Tackett, B.T. Chait, P. Badenhorst, C. Wu, C.D. Allis, A PHD ﬁnger of NURF couples
histone H3 lysine 4 trimethylation with chromatin remodelling, Nature 442
(2006) 86–90.
[79] M. Vermeulen, K.W. Mulder, S. Denissov, W.W. Pijnappel, F.M. van Schaik, R.A.
Varier, M.P. Baltissen, H.G. Stunnenberg, M. Mann, H.T. Timmers, Selective anchor-
ing of TFIID to nucleosomes by trimethylation of histone H3 lysine 4, Cell 131
(2007) 58–69.
[80] M. Vermeulen, H.C. Eberl, F. Matarese, H. Marks, S. Denissov, F. Butter, K.K. Lee, J.V.
Olsen, A.A. Hyman, H.G. Stunnenberg, M. Mann, Quantitative interaction proteo-
mics and genome-wide proﬁling of epigenetic histone marks and their readers,
Cell 142 (2010) 967–980.
[81] X. Li, E.A. Foley, K.R. Molloy, Y. Li, B.T. Chait, T.M. Kapoor, Quantitative chemical
proteomics approach to identify post-translational modiﬁcation-mediated
protein–protein interactions, J. Am. Chem. Soc. 134 (2012) 1982–1985.
[82] T.M. Spektor, J.C. Rice, Identiﬁcation and characterization of posttranslational
modiﬁcation-speciﬁc binding proteins in vivo by mammalian tethered catalysis,
Proc. Natl. Acad. Sci. U. S. A. 106 (2009) 14808–14813.
[83] T. Bartke, M. Vermeulen, B. Xhemalce, S.C. Robson, M. Mann, T. Kouzarides,
Nucleosome-interacting proteins regulated by DNA and histone methylation, Cell
143 (2010) 470–484.
[84] M. Nikolov, A. Stutzer, K. Mosch, A. Krasauskas, S. Soeroes, H. Stark, H. Urlaub, W.
Fischle, Chromatin afﬁnity puriﬁcation and quantitative mass spectrometry
667M. Soldi et al. / Biochimica et Biophysica Acta 1839 (2014) 657–668deﬁning the interactome of histone modiﬁcation patterns, Mol. Cell. Proteomics 10
(2011) (M110 005371).
[85] E. Shema-Yaacoby, M. Nikolov, M. Haj-Yahya, P. Siman, E. Allemand, Y. Yamaguchi,
C. Muchardt, H. Urlaub, A. Brik, M. Oren, W. Fischle, Systematic identiﬁcation of
proteins binding to chromatin-embedded ubiquitylated H2B reveals recruitment
of SWI/SNF to regulate transcription, Cell Rep. 4 (2013) 601–608.
[86] H.R. Jung, D. Pasini, K. Helin, O.N. Jensen, Quantitative mass spectrometry of
histones H3.2 and H3.3 in Suz12-deﬁcient mouse embryonic stem cells reveals
distinct, dynamic post-translational modiﬁcations at Lys-27 and Lys-36, Mol. Cell.
Proteomics 9 (2010) 838–850.
[87] J. Dejardin, R.E. Kingston, Puriﬁcation of proteins associated with speciﬁc genomic
Loci, Cell 136 (2009) 175–186.
[88] J.M. Antao, J.M. Mason, J. Dejardin, R.E. Kingston, Protein landscape at Drosophila
melanogaster telomere-associated sequence repeats, Mol. Cell. Biol. 32 (2012)
2170–2182.
[89] A. Unnikrishnan, P.R. Gafken, T. Tsukiyama, Dynamic changes in histone acetyla-
tion regulate origins of DNA replication, Nat. Struct. Mol. Biol. 17 (2010) 430–437.
[90] S.D. Byrum, A. Raman, S.D. Taverna, A.J. Tackett, ChAP–MS: a method for identiﬁca-
tion of proteins and histone posttranslational modiﬁcations at a single genomic
locus, Cell Rep. 2 (2012) 198–205.
[91] S.D. Byrum, S.D. Taverna, A.J. Tackett, Puriﬁcation of a speciﬁc native genomic locus
for proteomic analysis, Nucleic Acids Res. 41 (2013) e195.
[92] A. Barski, S. Cuddapah, K. Cui, T.Y. Roh, D.E. Schones, Z.Wang, G.Wei, I. Chepelev, K.
Zhao, High-resolution proﬁling of histone methylations in the human genome, Cell
129 (2007) 823–837.
[93] D.S. Johnson, A. Mortazavi, R.M. Myers, B. Wold, Genome-wide mapping of in vivo
protein–DNA interactions, Science 316 (2007) 1497–1502.
[94] P.J. Park, Epigenetics meets next-generation sequencing, Epigenetics 3 (2008)
318–321.
[95] P.J. Park, ChIP-seq: advantages and challenges of a maturing technology, Nat. Rev.
Genet. 10 (2009) 669–680.
[96] G. Robertson, M. Hirst, M. Bainbridge, M. Bilenky, Y. Zhao, T. Zeng, G. Euskirchen, B.
Bernier, R. Varhol, A. Delaney, N. Thiessen, O.L. Grifﬁth, A. He, M. Marra, M. Snyder,
S. Jones, Genome-wide proﬁles of STAT1 DNA association using chromatin immuno-
precipitation and massively parallel sequencing, Nat. Methods 4 (2007) 651–657.
[97] T.S. Mikkelsen,M. Ku, D.B. Jaffe, B. Issac, E. Lieberman, G. Giannoukos, P. Alvarez,W.
Brockman, T.K. Kim, R.P. Koche, W. Lee, E. Mendenhall, A. O'Donovan, A. Presser, C.
Russ, X. Xie, A. Meissner, M. Wernig, R. Jaenisch, C. Nusbaum, E.S. Lander, B.E.
Bernstein, Genome-wide maps of chromatin state in pluripotent and lineage-
committed cells, Nature 448 (2007) 553–560.
[98] J.P. Lambert, L. Mitchell, A. Rudner, K. Baetz, D. Figeys, A novel proteomics approach
for the discovery of chromatin-associated protein networks, Mol. Cell. Proteomics
8 (2009) 870–882.
[99] J.P. Lambert, J. Fillingham,M. Siahbazi, J. Greenblatt, K. Baetz, D. Figeys, Deﬁning the
budding yeast chromatin-associated interactome, Mol. Syst. Biol. 6 (2010) 448.
[100] M. Soldi, T. Bonaldi, The proteomic investigation of chromatin functional domains
reveals novel synergisms among distinct heterochromatin components, Mol. Cell.
Proteomics 12 (2013) 764–780.
[101] C.I. Wang, A.A. Alekseyenko, G. LeRoy, A.E. Elia, A.A. Gorchakov, L.M. Britton, S.J.
Elledge, P.V. Kharchenko, B.A. Garcia, M.I. Kuroda, Chromatin proteins captured
by ChIP-mass spectrometry are linked to dosage compensation in Drosophila,
Nat. Struct. Mol. Biol. 20 (2013) 202–209.
[102] E. Larschan, A.A. Alekseyenko, A.A. Gortchakov, S. Peng, B. Li, P. Yang, J.L. Workman,
P.J. Park, M.I. Kuroda, MSL complex is attracted to genes marked by H3K36
trimethylation using a sequence-independent mechanism, Mol. Cell 28 (2007)
121–133.
[103] O. Bell, T. Conrad, J. Kind, C. Wirbelauer, A. Akhtar, D. Schubeler, Transcription-
coupled methylation of histone H3 at lysine 36 regulates dosage compensation
by enhancing recruitment of the MSL complex in Drosophila melanogaster, Mol.
Cell. Biol. 28 (2008) 3401–3409.
[104] M.E. Gelbart, E. Larschan, S. Peng, P.J. Park, M.I. Kuroda, Drosophila MSL complex
globally acetylates H4K16 on the male X chromosome for dosage compensation,
Nat. Struct. Mol. Biol. 16 (2009) 825–832.
[105] D.K. Pokholok, C.T. Harbison, S. Levine, M. Cole, N.M. Hannett, T.I. Lee, G.W. Bell, K.
Walker, P.A. Rolfe, E. Herbolsheimer, J. Zeitlinger, F. Lewitter, D.K. Gifford, R.A.
Young, Genome-wide map of nucleosome acetylation and methylation in yeast,
Cell 122 (2005) 517–527.
[106] S.E. Ong, B. Blagoev, I. Kratchmarova, D.B. Kristensen, H. Steen, A. Pandey, M.
Mann, Stable isotope labeling by amino acids in cell culture, SILAC, as a simple
and accurate approach to expression proteomics, Mol. Cell. Proteomics 1
(2002) 376–386.
[107] S.E. Ong, M. Mann, A practical recipe for stable isotope labeling by amino acids in
cell culture SILAC, Nat. Protoc. 1 (2006) 2650–2660.
[108] S.E. Ong, M. Mann, Stable isotope labeling by amino acids in cell culture for quan-
titative proteomics, Methods Mol. Biol. 359 (2007) 37–52.
[109] M. Soldi, T. Bonaldi, The ChroP approach combines ChIP and mass spectrometry to
dissect locus-speciﬁc proteomic landscapes of chromatin, Vis. Exp. (2014) e51220,
http://dx.doi.org/10.3791/51220 (in press).
[110] D.N. Perkins, D.J. Pappin, D.M. Creasy, J.S. Cottrell, Probability-based protein identi-
ﬁcation by searching sequence databases using mass spectrometry data, Electro-
phoresis 20 (1999) 3551–3567.
[111] J. Cox, N. Neuhauser, A. Michalski, R.A. Scheltema, J.V. Olsen, M.Mann, Andromeda:
a peptide search engine integrated into the MaxQuant environment, J. Proteome
Res. 10 (2011) 1794–1805.
[112] T.S. Furey, ChIP-seq and beyond: new and improved methodologies to detect and
characterize protein–DNA interactions, Nat. Rev. Genet. 13 (2012) 840–852.[113] D. Doenecke, Cesium chloride gradients of chromatin after treatment with micro-
coccal nuclease, Cell 8 (1976) 59–64.
[114] H. Noll, M. Noll, Sucrose gradient techniques and applications to nucleosome struc-
ture, Methods Enzymol. 170 (1989) 55–116.
[115] A.W. Thorne, F.A. Myers, T.R. Hebbes, Native chromatin immunoprecipitation,
Methods Mol. Biol. 287 (2004) 21–44.
[116] P. Voigt, G. LeRoy, W.J. Drury III, B.M. Zee, J. Son, D.B. Beck, N.L. Young, B.A. Garcia,
D. Reinberg, Asymmetrically modiﬁed nucleosomes, Cell 151 (2012) 181–193.
[117] N.C. Hubner, A.W. Bird, J. Cox, B. Splettstoesser, P. Bandilla, I. Poser, A. Hyman, M.
Mann, Quantitative proteomics combined with BAC TransgeneOmics reveals
in vivo protein interactions, J. Cell Biol. 189 (2010) 739–754.
[118] N.C. Hubner, M. Mann, Extracting gene function from protein–protein interactions
using Quantitative BAC InteraCtomics QUBIC, Methods 53 (2011) 453–459.
[119] S. Driegen, R. Ferreira, A. van Zon, J. Strouboulis, M. Jaegle, F. Grosveld, S. Philipsen,
D. Meijer, A generic tool for biotinylation of tagged proteins in transgenic mice,
Transgenic Res. 14 (2005) 477–482.
[120] G. Strubbe, C. Popp, A. Schmidt, A. Pauli, L. Ringrose, C. Beisel, R. Paro, Polycomb
puriﬁcation by in vivo biotinylation tagging reveals cohesin and Trithorax
group proteins as interaction partners, Proc. Natl. Acad. Sci. U. S. A. 108 (2011)
5572–5577.
[121] J. Kim, A.B. Cantor, S.H. Orkin, J.Wang, Use of in vivo biotinylation to study protein–
protein and protein–DNA interactions in mouse embryonic stem cells, Nat. Protoc.
4 (2009) 506–517.
[122] P.N. Lau, P. Cheung, Elucidating combinatorial histone modiﬁcations and crosstalks
by coupling histone-modifying enzyme with biotin ligase activity, Nucleic Acids
Res. 41 (2012) e49.
[123] T. Kocher, R. Swart, K. Mechtler, Ultra-high-pressure RPLC hyphenated to an LTQ-
Orbitrap Velos reveals a linear relation between peak capacity and number of iden-
tiﬁed peptides, Anal. Chem. 83 (2011) 2699–2704.
[124] N. Nagaraj, N.A. Kulak, J. Cox, N. Neuhauser, K. Mayr, O. Hoerning, O. Vorm, M.
Mann, System-wide perturbation analysis with nearly complete coverage of the
yeast proteome by single-shot ultra HPLC runs on a bench top Orbitrap, Mol.
Cell. Proteomics 11 (2012) (M111 013722).
[125] A. Goffeau, B.G. Barrell, H. Bussey, R.W. Davis, B. Dujon, H. Feldmann, F. Galibert, J.D.
Hoheisel, C. Jacq, M. Johnston, E.J. Louis, H.W. Mewes, Y. Murakami, P. Philippsen,
H. Tettelin, S.G. Oliver, Life with 6000 genes, Science 274 (546) (1996) 563–567.
[126] M. Jinek, K. Chylinski, I. Fonfara, M. Hauer, J.A. Doudna, E. Charpentier, A program-
mable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity,
Science 337 (2012) 816–821.
[127] L. Cong, F.A. Ran, D. Cox, S. Lin, R. Barretto, N. Habib, P.D. Hsu, X. Wu, W. Jiang, L.A.
Marrafﬁni, F. Zhang, Multiplex genome engineering using CRISPR/Cas systems,
Science 339 (2013) 819–823.
[128] J.E. DiCarlo, J.E. Norville, P. Mali, X. Rios, J. Aach, G.M. Church, Genome engineering
in Saccharomyces cerevisiae using CRISPR-Cas systems, Nucleic Acids Res. 41 (2013)
4336–4343.
[129] T. Gaj, C.A. Gersbach, C.F. Barbas III, ZFN, TALEN, and CRISPR/Cas-basedmethods for
genome engineering, Trends Biotechnol. 31 (2013) 397–405.
[130] G. Liang, Y. Zhang, Embryonic stem cell and induced pluripotent stem cell: an
epigenetic perspective, Cell Res. 23 (2013) 49–69.
[131] S. Melcer, E. Meshorer, Chromatin plasticity in pluripotent cells, Essays Biochem.
48 (2010) 245–262.
[132] G. Natoli, Maintaining cell identity through global control of genomic organization,
Immunity 33 (2010) 12–24.
[133] A. Tarakhovsky, Logic of the inﬂammation-associated transcriptional response,
Adv. Immunol. 119 (2013) 107–133.
[134] J.V. Olsen, B. Blagoev, F. Gnad, B. Macek, C. Kumar, P. Mortensen, M. Mann, Global,
in vivo, and site-speciﬁc phosphorylation dynamics in signaling networks, Cell 127
(2006) 635–648.
[135] H.C. Eberl, C.G. Spruijt, C.D. Kelstrup, M. Vermeulen, M. Mann, A map of general
and specialized chromatin readers in mouse tissues generated by label-free inter-
action proteomics, Mol. Cell 49 (2013) 368–378.
[136] P. Picotti, B. Bodenmiller, L.N. Mueller, B. Domon, R. Aebersold, Full dynamic
range proteome analysis of S. cerevisiae by targeted proteomics, Cell 138
(2009) 795–806.
[137] L. Anderson, C.L. Hunter, Quantitative mass spectrometric multiple reaction moni-
toring assays for major plasma proteins, Mol. Cell. Proteomics 5 (2006) 573–588.
[138] P. Picotti, R. Aebersold, Selected reactionmonitoring-based proteomics: workﬂows,
potential, pitfalls and future directions, Nat. Methods 9 (2012) 555–566.
[139] B. Domon, Considerations on selected reactionmonitoring experiments: implications
for the selectivity and accuracy of measurements, Proteomics Clin. Appl. 6 (2012)
609–614.
[140] P. Picotti, O. Rinner, R. Stallmach, F. Dautel, T. Farrah, B. Domon, H. Wenschuh, R.
Aebersold, High-throughput generation of selected reaction-monitoring assays
for proteins and proteomes, Nat. Methods 7 (2010) 43–46.
[141] S. Gallien, E. Duriez, B. Domon, Selected reactionmonitoring applied to proteomics,
J. Mass Spectrom. 46 (2011) 298–312.
[142] S. Gallien, E. Duriez, C. Crone, M. Kellmann, T. Moehring, B. Domon, Targeted
proteomic quantiﬁcation on quadrupole-orbitrap mass spectrometer, Mol. Cell.
Proteomics 11 (2012) 1709–1723.
[143] S. Gallien, A. Bourmaud, S.Y. Kim, B. Domon, Technical considerations for large-
scale parallel reaction monitoring analysis, J. Proteomics. 100C (2014) 147–159.
[144] A.C. Peterson, J.D. Russell, D.J. Bailey, M.S. Westphall, J.J. Coon, Parallel reaction
monitoring for high resolution and high mass accuracy quantitative, targeted
proteomics, Mol. Cell. Proteomics 11 (2012) 1475–1488.
[145] J.C. Tran, L. Zamdborg, D.R. Ahlf, J.E. Lee, A.D. Catherman, K.R. Durbin, J.D. Tipton, A.
Vellaichamy, J.F. Kellie, M. Li, C. Wu, S.M. Sweet, B.P. Early, N. Siuti, R.D. LeDuc, P.D.
668 M. Soldi et al. / Biochimica et Biophysica Acta 1839 (2014) 657–668Compton, P.M. Thomas, N.L. Kelleher, Mapping intact protein isoforms in discovery
mode using top-down proteomics, Nature 480 (2011) 254–258.
[146] J.C. Tran, A.A. Doucette, Gel-eluted liquid fraction entrapment electrophoresis: an
electrophoretic method for broad molecular weight range proteome separation,
Anal. Chem. 80 (2008) 1568–1573.
[147] J.F. Kellie, A.D. Catherman, K.R. Durbin, J.C. Tran, J.D. Tipton, J.L. Norris, C.E.
Witkowski II, P.M. Thomas, N.L. Kelleher, Robust analysis of the yeast proteome
under 50 kDa by molecular-mass-based fractionation and top-down mass spec-
trometry, Anal. Chem. 84 (2012) 209–215.
[148] F. Lanucara, C.E. Eyers, Top-down mass spectrometry for the analysis of combina-
torial post-translational modiﬁcations, Mass Spectrom. Rev. 32 (2013) 27–42.
[149] L. Zamdborg, R.D. LeDuc, K.J. Glowacz, Y.B. Kim, V. Viswanathan, I.T. Spaulding, B.P.
Early, E.J. Bluhm, S. Babai, N.L. Kelleher, ProSight PTM 2.0: improved protein iden-
tiﬁcation and characterization for top down mass spectrometry, Nucleic Acids Res.
35 (2007) W701–W706.
[150] N.M. Karabacak, L. Li, A. Tiwari, L.J. Hayward, P. Hong, M.L. Easterling, J.N. Agar, Sensi-
tive and speciﬁc identiﬁcation of wild type and variant proteins from 8 to 669 kDa
using top-down mass spectrometry, Mol. Cell. Proteomics 8 (2009) 846–856.[151] D. Karolchik, G.P. Barber, J. Casper, H. Clawson, M.S. Cline, M. Diekhans,
T.R. Dreszer, P.A. Fujita, L. Guruvadoo, M. Haeussler, R.A. Harte, S. Heitner,
A.S. Hinrichs, K. Learned, B.T. Lee, C.H. Li, B.J. Raney, B. Rhead, K.R.
Rosenbloom, C.A. Sloan, M.L. Speir, A.S. Zweig, D. Haussler, R.M. Kuhn, W.J.
Kent, The UCSC Genome Browser database: 2014 update, Nucleic Acids Res.
42 (2014) D764–D770.
[152] P.V. Kharchenko, A.A. Alekseyenko, Y.B. Schwartz, A. Minoda, N.C. Riddle, J.
Ernst, P.J. Sabo, E. Larschan, A.A. Gorchakov, T. Gu, D. Linder-Basso, A.
Plachetka, G. Shanower, M.Y. Tolstorukov, L.J. Luquette, R. Xi, Y.L. Jung, R.W.
Park, E.P. Bishop, T.K. Canﬁeld, R. Sandstrom, R.E. Thurman, D.M. MacAlpine,
J.A. Stamatoyannopoulos, M. Kellis, S.C. Elgin, M.I. Kuroda, V. Pirrotta, G.H.
Karpen, P.J. Park, Comprehensive analysis of the chromatin landscape inDrosophila
melanogaster, Nature 471 (2011) 480–485.
